BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 129716)

  • 1. Metabolic clearance rate of dehydroisoandrosterone sulfate. V. Studies of essential hypertension complicating pregnancy.
    Gant NF; Madden JD; Chand S; Worley RJ; Strong JD; MacDonald PC
    Obstet Gynecol; 1976 Mar; 47(3):319-26. PubMed ID: 129716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic clearance rate of dehydroisoandrosterone sulfate. VI. Studies of eclampsia.
    Gant NF; Madden JD; Chand S; Worley RJ; Siiteri PK; MacDonald PC
    Obstet Gynecol; 1976 Mar; 47(3):327-30. PubMed ID: 129717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic clearance rate of dehydroisoandrosterone sulfate. IV. Acute effects of induced hypertension, hypotension, and naturesis in normal and hypertensive pregnancies.
    Gant NF; Madden JD; Siiteri PK; MacDonald PC
    Am J Obstet Gynecol; 1976 Jan; 124(2):143-8. PubMed ID: 129008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic clearance rate of dehydroisoandrosterone sulfate. VII. Effect of lateral versus supine recumbency.
    Singley T; Madden JD; Chand S; Worley RJ; MacDonald PC; Gant NF
    Obstet Gynecol; 1976 Apr; 47(4):419-22. PubMed ID: 130573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clearance rate of maternal plasma prehormones of placental estrogen formation.
    Gant NF; Worley RJ; MacDonald PC
    Perspect Nephrol Hypertens; 1976; 5():309-14. PubMed ID: 137386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic clearance rate of dehydroisoandrosterone sulfate. III. The effect of thiazide diuretics in normal and future pre-eclamptic pregnancies.
    Gant NF; Madden JD; Siteri PK; MacDonald PC
    Am J Obstet Gynecol; 1975 Sep; 123(2):159-63. PubMed ID: 126019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal considerations. Metabolic clearance rate of maternal plasma dehydroisoandrosterone sulfate.
    Worley RJ; Everett RB; Madden JD; MacDonald PC; Gant NF
    Semin Perinatol; 1978 Jan; 2(1):15-28. PubMed ID: 153584
    [No Abstract]   [Full Text] [Related]  

  • 8. End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia.
    Kreiser D; Baum M; Seidman DS; Fanaroff A; Shah D; Hendler I; Stevenson DK; Schiff E; Druzin ML
    J Perinatol; 2004 Apr; 24(4):213-7. PubMed ID: 15014533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral nifedipine pharmacokinetics in pregnancy-induced hypertension.
    Prevost RR; Akl SA; Whybrew WD; Sibai BM
    Pharmacotherapy; 1992; 12(3):174-7. PubMed ID: 1608848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of hypertension in pregnancy.
    Gant NF; Worley RJ
    Clin Obstet Gynaecol; 1977 Dec; 4(3):613-33. PubMed ID: 145921
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of mild pregnancy-induced hypertension remote from term.
    Nathan L; Gilstrap LC
    Semin Perinatol; 1994 Apr; 18(2):79-93. PubMed ID: 8066478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The arterial system in pre-eclampsia and chronic hypertension with superimposed pre-eclampsia.
    Hibbard JU; Korcarz CE; Nendaz GG; Lindheimer MD; Lang RM; Shroff SG
    BJOG; 2005 Jul; 112(7):897-903. PubMed ID: 15957989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF expression in the placenta from pregnancies complicated by hypertensive disorders.
    Sgambati E; Marini M; Zappoli Thyrion GD; Parretti E; Mello G; Orlando C; Simi L; Tricarico C; Gheri G; Brizzi E
    BJOG; 2004 Jun; 111(6):564-70. PubMed ID: 15198784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in midpregnancy as a predictor of gestational hypertension and pre-eclampsia.
    Rogers MS; Wang CC; Tam WH; Li CY; Chu KO; Chu CY
    BJOG; 2006 Sep; 113(9):1053-9. PubMed ID: 16956336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of pre-eclampsia and obstetric outcome in pregnancies of normotensive and hypertensive women attending a hospital specialist clinic.
    Lydakis C; Beevers M; Beevers DG; Lip GY
    Int J Clin Pract; 2001; 55(6):361-7. PubMed ID: 11501223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy.
    Gallery ED; Hunyor SN; Györy AZ
    Q J Med; 1979 Oct; 48(192):593-602. PubMed ID: 538221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic parameters of maternal amino acid metabolism and fetal growth.
    Hod M; Lapidot A
    Isr J Med Sci; 1996 Jul; 32(7):530-6. PubMed ID: 8756979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low plasma volume following pregnancy complicated by pre-eclampsia predisposes for hypertensive disease in a next pregnancy.
    Aardenburg R; Spaanderman ME; Ekhart TH; van Eijndhoven HW; van der Heijden OW; Peeters LL
    BJOG; 2003 Nov; 110(11):1001-6. PubMed ID: 14592585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium and platelets in normotensive and hypertensive human pregnancy.
    Kilby MD; Broughton Pipkin F; Symonds EM
    J Hypertens; 1992 Sep; 10(9):997-1003. PubMed ID: 1328382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone and enzyme assays in pregnancy. 3. The placental cystine-aminopeptidase and the urinary oestrogens in pregnancies complicated with essential hypertension, mild or severe pre-eclampsia.
    Christensen A
    Acta Endocrinol (Copenh); 1974 Jun; 76(2):353-63. PubMed ID: 4406595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.